Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12684391rdf:typepubmed:Citationlld:pubmed
pubmed-article:12684391lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0023473lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0162340lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0939537lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0008625lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0008626lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C1853126lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0282411lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0031525lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:12684391lifeskim:mentionsumls-concept:C0172367lld:lifeskim
pubmed-article:12684391pubmed:issue4lld:pubmed
pubmed-article:12684391pubmed:dateCreated2003-4-9lld:pubmed
pubmed-article:12684391pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12684391pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12684391pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12684391pubmed:languageenglld:pubmed
pubmed-article:12684391pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12684391pubmed:citationSubsetIMlld:pubmed
pubmed-article:12684391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12684391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12684391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12684391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12684391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12684391pubmed:statusMEDLINElld:pubmed
pubmed-article:12684391pubmed:monthAprlld:pubmed
pubmed-article:12684391pubmed:issn1078-0432lld:pubmed
pubmed-article:12684391pubmed:authorpubmed-author:PerrottiDanil...lld:pubmed
pubmed-article:12684391pubmed:authorpubmed-author:CaligiuriMich...lld:pubmed
pubmed-article:12684391pubmed:authorpubmed-author:MarcucciGuido...lld:pubmed
pubmed-article:12684391pubmed:issnTypePrintlld:pubmed
pubmed-article:12684391pubmed:volume9lld:pubmed
pubmed-article:12684391pubmed:ownerNLMlld:pubmed
pubmed-article:12684391pubmed:authorsCompleteYlld:pubmed
pubmed-article:12684391pubmed:pagination1248-52lld:pubmed
pubmed-article:12684391pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12684391pubmed:meshHeadingpubmed-meshheading:12684391...lld:pubmed
pubmed-article:12684391pubmed:meshHeadingpubmed-meshheading:12684391...lld:pubmed
pubmed-article:12684391pubmed:meshHeadingpubmed-meshheading:12684391...lld:pubmed
pubmed-article:12684391pubmed:meshHeadingpubmed-meshheading:12684391...lld:pubmed
pubmed-article:12684391pubmed:meshHeadingpubmed-meshheading:12684391...lld:pubmed
pubmed-article:12684391pubmed:meshHeadingpubmed-meshheading:12684391...lld:pubmed
pubmed-article:12684391pubmed:meshHeadingpubmed-meshheading:12684391...lld:pubmed
pubmed-article:12684391pubmed:year2003lld:pubmed
pubmed-article:12684391pubmed:articleTitleUnderstanding the molecular basis of imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance. Commentary re: A. N. Mohamed et al., The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations. Clin. Cancer Res., 9: 1333-1337, 2003.lld:pubmed
pubmed-article:12684391pubmed:affiliationDivision of Hematology and Oncology, Department of Internal Medicine, The James Cancer Hospital and The Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio 43210, USA. marcucci-1@medctr.osu.edulld:pubmed
pubmed-article:12684391pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12684391pubmed:publicationTypeCommentlld:pubmed
pubmed-article:12684391pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12684391pubmed:publicationTypeReviewlld:pubmed
pubmed-article:12684391pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12684391lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12684391lld:pubmed